- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- POLB 001 LPS Challenge Trial Paper Published
- Exercise of Options & Total Voting Rights
- Letter to Shareholders – 2025 a year of progress
- POLB 001 to feature in CRS research programme
- POLB 001 European Patent granted
- Interim Results for the six months to 30 June 2025
- POLB 001 Phase 2a Trial Update
- Notification of Major Holdings
- Director/PDMR Shareholding
- Results of GM and AGM Meetings
More ▼
Key statistics
On Friday, Poolbeg Pharma PLC (POLB:LSE) closed at 4.60, -11.54% below its 52-week high of 5.20, set on Jan 20, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 4.40 |
|---|---|
| High | 4.60 |
| Low | 4.60 |
| Bid | 4.00 |
| Offer | 5.00 |
| Previous close | 4.40 |
| Average volume | 3.25m |
|---|---|
| Shares outstanding | 697.20m |
| Free float | 366.82m |
| P/E (TTM) | -- |
| Market cap | 32.07m GBP |
| EPS (TTM) | -0.0114 GBP |
Data delayed at least 20 minutes, as of Feb 06 2026 16:42 GMT.
More ▼
